Semantic Scholar uses AI to extract papers important to this topic.
Dear Editor, In December 2019, a novel pneumonia caused by a previously unknown pathogen emerged in Wuhan, a city of 11 million… Expand
Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in… Expand With few exceptions, the most commonly recommended triple Helicobacter pylori regimen (proton pump inhibitor (PPI), amoxicillin… Expand BACKGROUND
Vancomycin is the only US Food and Drug Administration-approved drug for treatment of Clostridium difficile infection… Expand ABSTRACT Nitazoxanide (NTZ) exhibits broad-spectrum activity against anaerobic bacteria and parasites and the ulcer-causing… Expand Nitazoxanide is a new thiazolide antiparasitic agent that shows excellent in vitro activity against a wide variety of protozoa… Expand Nitazoxanide (Alinia, Romark Laboratories) was synthesized based on the structure of niclosamide. In vitro studies have… Expand BACKGROUND
Cryptosporidiosis in children in developing countries causes persistent diarrhoea and malnutrition and is associated… Expand A prospective randomized, double-blind, placebo-controlled study was conducted in 50 adults and 50 children from the Nile delta… Expand OBJECTIVES
Nitazoxanide (N), a new broad-spectrum parasiticidal agent, is rapidly deacetylated to tizoxanide (T). The objective… Expand